It may be hypothesized that renalase supplementation, in a likely demeanor, may benefit failing hearts, given the wealth of evidence that cardiac and renal diseases share some pathomechanisms [86] and that modulating the NAD+/sirtuin axis, potentially by renalase, may be a clinically relevant approach for developing new therapies. Here, RNLS is linked to kidney disorder.